Back

Pharmacological mitochondrial stabilization to prevents adverse cardiac remodeling following MI using empagliflozin

25 May 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Basic Science - Metabolism Ischaemia, Infarction, Cardioprotection HFA Premium Access Heart Failure 2019

About the speaker

Photo
Professor Domingo Pascual Figal

Virgen de la Arrixaca University Clinical Hospital, Murcia (Spain)

17 More presentations in this session

Presentation thumbnail
Basic Science - Metabolism - Poster Discussant - 10:00-11:00.
Presentation thumbnail
Empagliflozin modulates GTP enzyme cyclohydrolase 1 in chronic heart failure
Professor D. Pascual Figal (Murcia, ES)
Abstract
Presentation thumbnail
The myocardial metabolism shift results to cardiomyocyte dedifferentiation in dilated cardiomyopathy and chronic heart failure.
Presentation thumbnail
Empagliflozin ameliorates post-infarction cardiac remodeling through overexpression of GTP enzyme cyclohydrolase 1
Professor D. Pascual Figal (Murcia, ES)
Abstract
Presentation thumbnail
Age-specific features of cardioprotective action of meldonium under the experimental severe hypoosomolar hyperhydration
Doctor N. Demikhova (Sumy, UA)
Abstract

Access the full session

Session thumbnail
Poster Session 2 - Basic Science - Metabolism

The Event

Event poster

Heart Failure 2019

25 May - 28 May 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources